SSB and type 2 diabetes mellitus: Several evidences support a role for α-LA as a mitigator of OS in type 2 diabetes [49], this drug being also used in the treatment of atherosclerosis, cardiovascular diseases, cataracts, neurodegenerative diseases, liver diseases and AIDS [50].